InspireMD, Inc.
US ˙ NasdaqCM ˙ US45779A8466

Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael Berman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael Berman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NSPR / InspireMD, Inc. Director 244,994
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael Berman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases NSPR / InspireMD, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in NSPR / InspireMD, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2023-05-12 NSPR BERMAN MICHAEL 122,497 1.6327 122,497 1.6327 200,001 173 3.7500 259,364 129.68
2021-02-08 NSPR BERMAN MICHAEL 80,640 0.6200 5,376 9.3000 49,997
2013-04-16 NSPR BERMAN MICHAEL 30,000 2.0000 1,111 54.0000 60,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NSPR / InspireMD, Inc. Insider Trades
Insider Sales NSPR / InspireMD, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in NSPR / InspireMD, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NSPR / InspireMD, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Michael Berman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-23 2025-06-29 4 NSPR InspireMD, Inc.
Common Stock
X - Other 61,248 244,994 33.33 1.38 84,688 338,753
2025-01-10 2025-01-07 4 NSPR InspireMD, Inc.
Common Stock
A - Award 32,491 264,533 14.00
2024-06-26 2024-06-24 4 NSPR InspireMD, Inc.
Common Stock
X - Other 61,249 183,746 50.00 1.38 84,689 254,066
2024-01-25 2024-01-23 4 NSPR InspireMD, Inc.
Common Stock
A - Award 29,032 232,042 14.30
2024-01-11 2024-01-02 4 NSPR InspireMD, Inc.
Common Stock
A - Award 3,782 203,010 1.90
2023-10-04 2023-10-02 4 NSPR InspireMD, Inc.
Common Stock
A - Award 3,106 199,228 1.58
2023-07-05 2023-07-01 4 NSPR InspireMD, Inc.
Common Stock
A - Award 4,351 196,122 2.27
2023-05-19 2023-05-17 4 NSPR InspireMD, Inc.
Common Stock
A - Award 149,260 192,087 348.52
2023-05-16 2023-05-12 4 NSPR InspireMD, Inc.
Common Stock
P - Purchase 122,497 122,497 1.63 200,001 200,001
2023-04-04 2023-04-01 4 NSPR InspireMD, Inc.
Common Stock
A - Award 9,491 42,827 28.47
2021-11-12 2021-11-10 4 NSPR InspireMD, Inc.
Options to purchase common stock (right to buy)
A - Award 5,749 5,749
2021-11-12 2021-11-10 4 NSPR InspireMD, Inc.
Common Stock
A - Award 17,248 33,336 107.21
2021-02-10 2021-02-08 4 NSPR InspireMD, Inc.
Warrants
P - Purchase 40,320 40,320 0.62 24,998 24,998
2021-02-10 2021-02-08 4 NSPR InspireMD, Inc.
Common Stock
P - Purchase 80,640 241,275 50.20 0.62 49,997 149,590
2021-02-10 2020-08-31 4 NSPR InspireMD, Inc.
Options to purchase common stock (right to buy)
A - Award 52,678 52,692 376,271.43
2020-09-02 2020-08-31 4 NSPR InspireMD, Inc.
Options to purchase common stock (right to buy)
A - Award 52,678 52,692 376,271.43
2020-09-02 2020-08-31 4 NSPR InspireMD, Inc.
Common Stock
A - Award 158,033 160,635 6,073.52
2019-02-06 2019-02-04 4 NSPR InspireMD, Inc.
Common Stock
A - Award 130,000 130,005 2,600,000.00
2016-12-08 2016-12-07 4 NSPR InspireMD, Inc.
Options (right to buy)
A - Award 12,500 12,500
2016-07-05 2016-06-30 4 NSPR InspireMD, Inc.
Options (right to buy)
A - Award 111,800 111,800
2016-01-28 2016-01-26 4 NSPR InspireMD, Inc.
Options (right to buy)
D - Sale to Issuer 5,409 0 -100.00
2016-01-28 2016-01-26 4 NSPR InspireMD, Inc.
Options (right to buy)
D - Sale to Issuer 3,805 0 -100.00
2016-01-28 2016-01-26 4 NSPR InspireMD, Inc.
Options (right to buy)
D - Sale to Issuer 5,000 0 -100.00
2016-01-28 2016-01-26 4 NSPR InspireMD, Inc.
Options (right to buy)
D - Sale to Issuer 12,442 0 -100.00
2016-01-28 2016-01-26 4 NSPR InspireMD, Inc.
Common Stock
A - Award 1 3,001 0.03
2015-10-02 2015-09-30 4 NSPR InspireMD, Inc.
Options (right to buy)
A - Award 74,559 74,559
2015-07-02 2015-06-30 4 NSPR InspireMD, Inc.
Option (right to buy)
A - Award 45,405 45,405
2015-04-06 2015-03-31 4 NSPR InspireMD, Inc.
Option (right to buy)
A - Award 40,127 40,127
2015-02-02 2015-01-26 4 NSPR InspireMD, Inc.
Stock Options (right to buy)
A - Award 54,088 54,088
2015-01-07 2015-01-05 4 NSPR InspireMD, Inc.
Options to Purchase Common Stock
J - Other 38,045 38,045
2014-01-31 2014-01-29 4 NSPR InspireMD, Inc.
Options to Purchase Common Stock
A - Award 50,000 50,000
2013-04-17 2013-04-16 4 NSPR InspireMD, Inc.
Common Stock
P - Purchase 30,000 30,000 2.00 60,000 60,000
2013-02-11 2013-02-07 4 NSPR.OB InspireMD, Inc.
Options to Purchase Common Stock
A - Award 124,415 124,415
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)